Mark Dipaolo
Voorzitter bij INNOVIVA, INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Mark Dipaolo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INNOVIVA, INC. | Voorzitter | 22-05-2023 | - |
| Directeur/Bestuurslid | 12-02-2018 | 22-05-2023 | |
| Independent Dir/Board Member | 12-02-2018 | 01-05-2023 | |
| SARISSA CAPITAL ACQUISITION CORP. | Corporate Officer/Principal | 20-10-2020 | - |
| AMARIN CORPORATION PLC | Directeur/Bestuurslid | 28-02-2023 | - |
| Independent Dir/Board Member | 28-02-2023 | - |
Loopbaan van Mark Dipaolo
Eerdere bekende functies van Mark Dipaolo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | Directeur/Bestuurslid | 02-08-2017 | 13-09-2018 |
| Independent Dir/Board Member | 02-08-2017 | 13-09-2018 | |
Willkie Farr & Gallagher LLP
 Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Willkie Farr & Gallagher LLP engages in the provision of legal services. It specializes in antitrust and competition, asset management, business reorganization and restructuring, communications and media, corporate and financial services, cybersecurity and privacy, energy, and executive compensation and employee benefits practice areas. The company was founded in 1888 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-08-2017 | 01-09-2018 |
Opleiding van Mark Dipaolo
| Fordham University | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Canada | 2 |
| Ierland | 2 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| AMARIN CORPORATION PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Willkie Farr & Gallagher LLP
Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Willkie Farr & Gallagher LLP engages in the provision of legal services. It specializes in antitrust and competition, asset management, business reorganization and restructuring, communications and media, corporate and financial services, cybersecurity and privacy, energy, and executive compensation and employee benefits practice areas. The company was founded in 1888 and is headquartered in New York, NY. | Commercial Services |
Sarissa Capital Acquisition Corp.
 Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Sarissa Capital Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination with one or more businesses. The company was founded on August 12, 2020 and is headquartered in Greenwich, CT. | Finance |
- Beurs
- Insiders
- Mark Dipaolo
- Ervaring
